Highland Park, IL (PRWEB) March 30, 2013
Well-credentialed faculty—many with affiliations to prestigious institutions such as Yale and Harvard—will present lectures, interactive panel discussions and the latest clinical applications at the upcoming 14th Clinical Applications in Age Management Conference, announced the Age Management Medicine Group (AMMG), a leader in providing innovative CME-accredited events for physicians and healthcare professionals. The AMMG conference, held from May 2 through May 5 at the Westin Diplomat Resort & Spa in Hollywood, Florida, allows physician attendees to earn 27 AMA PRA Category 1 CME Credits.
The AMMG strives to offer academically sound curriculum that is evidence-based, poised on the forefront of 21st century medicine and delivered by medical professionals who are experts in their field and who can provide comprehensive learning materials for the non-commercial course syllabus.
“Our faculty are highly qualified and well-versed in their areas, offering physician attendees a wide spectrum of leading-edge topics, from genetic and inflammatory markers of cardiovascular disease to futuristic protocols—for example, telomere science, genetic testing and stem cell treatments—and even controversial issues such as HIV and aging, ” AMMG Chairman/Cofounder Greg Fillmore said.
Some of the 38 accomplished physicians delivering such pertinent presentations at the upcoming AMMG conference include . . .
Cardiovascular Disease in Women. Dr. Charles L. Schulman, Assistant Clinical Professor of Medicine, Harvard Medical School; Senior Physician at Beth Israel-Deaconess Medical Center
- Where is Age Management Medicine Going with 21st Century Medical Science: Telomeres, Genetic Testing, Stem Cells: Panel discussion includes Dr. Florence Comite—a courtesy-attending physician at Yale-New Haven Hospital, a Yale University School of Medicine graduate and longtime leader in the evolution in wellness-based health care/preventive medicine; Dr. Christopher Centeno, an international expert/specialist in regenerative medicine, chair of multiple international research-based conferences, Medical Director of the Centeno-Schultz Clinic in Colorado
- Update on Cardiovascular Risk Factors. Ernst von Schwarz, MD, PhD, Director Cardiac Support Program (Cedars Sinai Medical Center), Professor of Medicine (David Geffen School of Medicine at UCLA), Chief Medical Officer of Heart Institute of Southern California
- Use and Safety of Bioidentical Hormonal Replacement Therapy in Women/Case Study. Dr. Edward R. Rosick, Chair of Family & Community Medicine Department (Michigan State University - College of Osteopathic Medicine), accomplished author, internationally known speaker on integrative/holistic medicine
- Nitric Oxide Deficiency & Restoration: New Discoveries in Cardiovascular & Sexual Health. Nathan S. Bryan, PhD, Professor of Medicine (University of Texas/Health Science Center), was Kirschstein Fellow at Boston University School of Medicine, an inventor on several US patents, an author of highly cited papers
- HIV and Aging. Dr. Susan C. Ball, Associate Professor of Medicine and Associate Professor of Public Health for New York Presbyterian Hospital, Weill Cornell Medical College
- Inflammatory Markers of Cardiovascular Disease. Dr. Marc S. Penn, a cardiologist, Director of Research at Summa Cardiovascular Institute in Akron, OH, Professor of Medicine and Integrative Medical Sciences at Northeast Ohio Medical University, author of over 100-peer-reviewed manuscripts, active inventor who has generated intellectual property in the fields of diagnostics, biologics and devices
- 21st Century Plague: Modernized Food and its Collateral Damage. Dr. Arden Anderson, Medical Director of Crossroads Healing Arts, board-certified in Public Health, consultant for farm management/soil/plan nutrition, author of numerous books/manuals/courses, practiced flight medicine for 10 years in the USAF Reserves traveling over 100,000 miles annually
- Genetic Markers of Cardiovascular Disease. Dr. H. Robert Superko, founder of Berkeley HeartLab, a prolific author of over 120 peer-reviewed articles, seated on editorial boards of prestigious journals, including the “Journal of Cardiovascular Risk and Preventative Cardiology”
- Endothelial Glycocalyx: Early Marker & Therapeutic Target of Vascular Complications. Hans Vink, PhD, Professor of Circulatory Physics (University of Amsterdam/Netherlands), Associate Professor of Physiology (Maastricht University/Netherlands), Chief Science Officer (GlycoCheck BV)
“As more traditional physicians embrace age management medicine, our AMMG conferences are experiencing a growing influx of attendees who respect and appreciate our delivery of consistent, evidence-based information that is groundbreaking, relevant and presented by leaders in the field,”AMMG Executive Director/Cofounder Rick Merner said.
For more information about AMMG or their upcoming May conference, visit them online.
About Age Management Medicine Group
The Age Management Medicine Group (AMMG) is led by Executive Director/Cofounder Rick Merner and Conference Chairman/Cofounder Greg Fillmore. AMMG provides education and information to physicians and healthcare professionals on age management medicine—a proactive medical approach for optimized health and the delay/prevention of age-related disease. Education is presented through evidence-based, continuing medical education conferences, workshops, seminars, publications and web media. AMMG membership consists of leading healthcare professionals, physicians, practitioners, researchers, medical associations and providers of products and services.